Friday, October 2, 2026
27 C
Bengaluru

Cipla appoints Shivam Puri as CEO of One India Business

Shivam Puri has been appointed Chief Executive Officer of Cipla’s One India Business, effective July 1, 2026. This marks a significant leadership transition for one of India’s leading pharmaceutical organizations as it continues to strengthen its presence across healthcare and consumer wellness segments.

Puri brings more than 23 years of cross-industry experience spanning healthcare and fast-moving consumer goods, with deep expertise in commercial leadership, consumer marketing, and business strategy. His career reflects a consistent focus on building scalable, consumer-centric businesses and driving sustained organizational growth.

Prior to this elevation, he served as Managing Director and Chief Executive Officer of Cipla Health, where he played a central role in shaping and expanding the company’s consumer healthcare portfolio. Under his leadership, Cipla Health strengthened its presence across multiple wellness categories and evolved into a more diversified and growth-focused business within the broader Cipla ecosystem.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Topics

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...

Medical Reps—Lessons From The West: The Old Model is Dead

The Core Conclusion The Western pharma industry is not simply...
spot_img

Related Articles

spot_imgspot_img